REFERENCES
- Alexander B D, Pfaller M A. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis 2006; 43(Suppl 1)15–27
- Kullberg BJ, Oude Lashof A M. Epidemiology of opportunistic invasive mycoses. Eur J Med Res 2002; 7: 183–191
- Athanassiadou F, Tragiannidis A, Kourti M, et al. Invasive fungal infections in children with hematological malignancies: a 5-year study. Pediatr Hematol Oncol. 2006; 23: 163–166
- Rosen G P, Nielsen K, Glenn S, et al. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol 2005; 27: 135–140
- Masood A, Sallah S. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leuk Res 2005; 29: 493–501
- Pfaller M A, Pappas P G, Wingard J R. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006; 43(Suppl 1)3–14
- Gorschluter M, Mey U, Strehl J, et al. Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis 2006; 6: 35
- Reuter C W, Morgan M A, Bange F C, et al. Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients. Clin Infect Dis 2005; 41: 1365–1366
- Pfaller M A, Boyken L, Hollis R J, et al. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. J Clin Microbiol 2006; 44: 3533–3538
- Sendid B, Lacroix C, Bougnoux M E. Is Candida kefyr an emerging pathogen in patients with oncohematological diseases?. Clin Infect Dis 2006; 43: 666–667
- Muller FM, Trusen A, Weig M. Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children. Eur J Pediatr 2002; 161: 563–574
- Ali R, Ozcelik T. Invasive pulmonary aspergillosis in acute leukemia: current issues for pathogenesis, diagnosis and treatment. Curr Respir Med Rev 2006; 2: 3–13
- Leav B A, Fanburg B, Hadley S. Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med 2000; 343: 586
- Monlun E, de Blay F, Berton C, et al. Invasive pulmonary aspergillosis with cerebromeningeal involvement after short-term intravenous corticosteroid therapy in a patient with asthma. Respir Med 1997; 91: 435–437
- Agusti C, Rano A, Aldabo I, Torres A. Fungal pneumonia, chronic respiratory diseases and glucocorticoids. Med Mycol. 2006; 44: 207–211, (Suppl)
- Bernard A, Caillot D, Couaillier J F, et al. Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg 1997; 64: 1441–1447
- Foell J L, Fischer M, Seibold M, et al. Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL. Pediatr Blood Cancer 2006, Jan 20. [Epub ahead of print]
- Molle M, Blaschke-Hellmessen R, Schuler U, et al. Disseminated aspergillosis and mucormycosis: a case report. Mycoses 1996; 39(Suppl 1)59–64
- Wagner D, Sander A, Bertz H, et al. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection. 2005; 33: 397–400
- Lin S J, Schranz J, Teutsch S M. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358–366
- Tortorano A M, Peman J, Bernhardt H. ECMM Working Group on Candidaemia. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317–322